Literature DB >> 27859736

Relationship between A163G osteoprotegerin gene polymorphism and other osteoporosis parameters in Roma and non-Roma postmenopausal women in eastern Slovakia.

Marta Mydlárová Blaščáková1, Ľudmila Blaščáková2, Janka Poráčová1, Jozef Mydlár3, Janka Vašková4, Jarmila Bernasovská1, Iveta Boroňová1, Eva Petrejčíková1, Ivan Bernasovský5.   

Abstract

BACKGROUND: The study was focused on evaluating the possible correlation between biochemical, anthropometric, and genetic indicators of osteoporosis in postmenopausal women. The frequency of genotypes and differences in measured parameters were evaluated within two ethnically different groups of women in Slovakia.
METHODS: The study included 310 postmenopausal women divided into non-Roma and Roma groups. Based on results of densitometry, they were divided into control groups and women with osteoporosis and osteopenia. In all women, a genetic analysis of polymorphism of osteoprotegerin gene promotor region (A163G) was provided along with measurement of indicators of bone tissue metabolism.
RESULTS: There is a particularly low incidence of osteoporosis in Roma women. We found a correlation between bone mineral density (BMD), body mass index, and waist and hip circumference in women with osteoporosis and in Roma women with osteopenia. The frequency of the AG genotype was higher in non-Roma women with osteoporosis, but reached only 10.7% in Roma women with osteopenia. While the presence of the G allele in the non-Roma population was accompanied by higher BMD and markers of osteoformation, it was accompanied by significantly higher concentrations of parathyroid hormone in the Roma population.
CONCLUSION: The presence of the AG genotype has a different effect on bone metabolism in two ethnically diverse populations of women in Slovakia. In the general population, the presence of the G allele exhibited protective effects consistent with other studies, but in Roma population this appears to be the allele A. However, this requires a further study for confirmation and more detailed characterization of the differences between populations that have this work indicated.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Roma (Gypsy) women; biochemical parameters; osteoporosis; osteoprotegerin polymorphism; postmenopausal women

Mesh:

Substances:

Year:  2016        PMID: 27859736      PMCID: PMC6816896          DOI: 10.1002/jcla.22093

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  37 in total

Review 1.  Osteoprotegerin and Vascular Calcification: Clinical and Prognostic Relevance.

Authors:  Sandra Makarović; Zorin Makarović; Robert Steiner; Ivan Mihaljević; Jasminka Milas-Ahić
Journal:  Coll Antropol       Date:  2015-06

2.  Increased 2-hydroxylation of estrogen is associated with lower body fat and increased lean body mass in postmenopausal women.

Authors:  Nicola Napoli; Swapna Vattikuti; Jayasree Yarramaneni; Tusar K Giri; Srenath Nekkalapu; Clifford Qualls; Reina C Armamento-Villareal
Journal:  Maturitas       Date:  2012-03-03       Impact factor: 4.342

Review 3.  Bone disease in thalassaemia major: recent advances in pathogenesis and clinical aspects.

Authors:  Nicos Skordis; Meropi Toumba
Journal:  Pediatr Endocrinol Rev       Date:  2011-03

4.  Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Authors:  N Udagawa; N Takahashi; E Jimi; K Matsuzaki; T Tsurukai; K Itoh; N Nakagawa; H Yasuda; M Goto; E Tsuda; K Higashio; M T Gillespie; T J Martin; T Suda
Journal:  Bone       Date:  1999-11       Impact factor: 4.398

5.  Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women.

Authors:  T Thomas; B Burguera; L J Melton; E J Atkinson; W M O'Fallon; B L Riggs; S Khosla
Journal:  Bone       Date:  2001-08       Impact factor: 4.398

6.  TNFRSF11B gene polymorphisms, bone mineral density, and fractures in Slovak postmenopausal women.

Authors:  Iveta Boroňová; Jarmila Bernasovská; Soňa Mačeková; Eva Petrejčíková; Zlatica Tomková; Ján Kľoc; Janka Poráčová; Marta Mydlárová Blaščáková; Eva Litavcová
Journal:  J Appl Genet       Date:  2014-10-17       Impact factor: 3.240

7.  Bone mineral density changes during the menopause transition in a multiethnic cohort of women.

Authors:  Joel S Finkelstein; Sarah E Brockwell; Vinay Mehta; Gail A Greendale; MaryFran R Sowers; Bruce Ettinger; Joan C Lo; Janet M Johnston; Jane A Cauley; Michelle E Danielson; Robert M Neer
Journal:  J Clin Endocrinol Metab       Date:  2007-12-26       Impact factor: 5.958

Review 8.  SHARPIN is a key regulator of immune and inflammatory responses.

Authors:  Zhe Wang; Christopher S Potter; John P Sundberg; Harm Hogenesch
Journal:  J Cell Mol Med       Date:  2012-10       Impact factor: 5.310

9.  "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density".

Authors:  María Piedra; María T García-Unzueta; Ana Berja; Blanca Paule; Bernardo A Lavín; Carmen Valero; José A Riancho; José A Amado
Journal:  BMC Med Genet       Date:  2011-12-20       Impact factor: 2.103

10.  Neoplastic bone marrow niche: hematopoietic and mesenchymal stem cells.

Authors:  Najmaldin Saki; Saeid Abroun; Majid Farshdousti Hagh; Farahnaz Asgharei
Journal:  Cell J       Date:  2011-09-23       Impact factor: 2.479

View more
  1 in total

1.  Different prevalence of T2DM risk alleles in Roma population in comparison with the majority Czech population.

Authors:  Jaroslav A Hubáček; Lenka Šedová; Věra Olišarová; Věra Adámková; Valérie Tóthová
Journal:  Mol Genet Genomic Med       Date:  2020-06-24       Impact factor: 2.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.